JNJ

170.73

-0.23%↓

NVS

117.78

-0.02%↓

ABT

130.77

+0.52%↑

TMO

466.56

-0.22%↓

ISRG

476.87

-1.3%↓

JNJ

170.73

-0.23%↓

NVS

117.78

-0.02%↓

ABT

130.77

+0.52%↑

TMO

466.56

-0.22%↓

ISRG

476.87

-1.3%↓

JNJ

170.73

-0.23%↓

NVS

117.78

-0.02%↓

ABT

130.77

+0.52%↑

TMO

466.56

-0.22%↓

ISRG

476.87

-1.3%↓

JNJ

170.73

-0.23%↓

NVS

117.78

-0.02%↓

ABT

130.77

+0.52%↑

TMO

466.56

-0.22%↓

ISRG

476.87

-1.3%↓

JNJ

170.73

-0.23%↓

NVS

117.78

-0.02%↓

ABT

130.77

+0.52%↑

TMO

466.56

-0.22%↓

ISRG

476.87

-1.3%↓

Search

TruBridge Inc

Открыт

СекторЗдравоохранение

20.77 -1.56

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

19.83

Макс.

21.17

Ключевые показатели

By Trading Economics

Доход

3.8M

459K

Продажи

-3.6M

87M

Рентабельность продаж

0.526

Сотрудники

3,200

EBITDA

-2.5M

8.2M

Рекомендации

By TipRanks

Рекомендации

Покупка

Прогноз на 12 месяцев

+41.19% upside

Дивиденды

By Dow Jones

Следующий отчет о доходах

7 авг. 2025 г.

Рыночная статистика

By TradingEconomics

Рыночная капитализация

-45M

347M

Предыдущая цена открытия

22.33

Предыдущая цена закрытия

20.77

Новостные настроения

By Acuity

50%

50%

175 / 374 Рейтинг в Healthcare

TruBridge Inc График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

4 авг. 2025 г., 21:42 UTC

Отчет
Приобретения, слияния, поглощения

Cabot to Acquire Mexico Carbon Manufacturing From Bridgestone

4 авг. 2025 г., 21:21 UTC

Отчет
Главные движущие силы рынка

Vertex Stock Falls After Pain-Drug Setback, Despite Stronger 2Q Earnings -- Update

4 авг. 2025 г., 20:45 UTC

Отчет

Vertex Pharmaceuticals Swings to 2Q Profit as Sales Climb

4 авг. 2025 г., 19:15 UTC

Главные движущие силы рынка

TransMedics Group Shares Rise on FDA Approval for Clinical Trial

4 авг. 2025 г., 23:41 UTC

Обсуждения рынка

Global Forex and Fixed Income Roundup: Market Talk

4 авг. 2025 г., 23:41 UTC

Обсуждения рынка

Nikkei May Rise on Fed Stimulus Hopes

4 авг. 2025 г., 23:28 UTC

Обсуждения рынка

Global Equities Roundup: Market Talk

4 авг. 2025 г., 23:28 UTC

Обсуждения рынка

Gold Seen Stuck in Range as Investors Await Fed's Next Move -- Market Talk

4 авг. 2025 г., 21:30 UTC

Отчет

Palantir Stock Jumps. Earnings Blew Past Wall Street's Expectations. -- Barrons.com

4 авг. 2025 г., 21:21 UTC

Отчет
Приобретения, слияния, поглощения

Berkshire Stock Was Hammered Monday. It's Like 1999 Again. -- Barrons.com

4 авг. 2025 г., 21:18 UTC

Отчет

Palantir Stock Jumps. Earnings Blew Past Wall Street's Expectations. -- Barrons.com

4 авг. 2025 г., 20:25 UTC

Обсуждения рынка

India Hits Back Over Russian Oil Purchases -- Market Talk

4 авг. 2025 г., 20:25 UTC

Отчет

Transocean 2Q Loss $938M >RIG

4 авг. 2025 г., 20:25 UTC

Отчет

Transocean 2Q Loss/Shr $1.06 >RIG

4 авг. 2025 г., 20:18 UTC

Отчет

Palantir Stock Jumps. Earnings Blew Past Wall Street's Stratospheric Expectations. -- Barrons.com

4 авг. 2025 г., 20:15 UTC

Отчет

Vertex Pharma: Guidance Includes Immaterial Cost Impact From Tariffs in 2025 Based on Currently Known Tariff Rates and Regulations >VRTX

4 авг. 2025 г., 20:14 UTC

Отчет

Vertex Pharmaceuticals Reiterated FY25 Fincl Guidance >VRTX

4 авг. 2025 г., 20:14 UTC

Отчет

Vertex Pharma: Mark Bunnage, D.Phil., SVP of Global Research, to Assume Role of CSO Effective Feb 1, 2026 >VRTX

4 авг. 2025 г., 20:14 UTC

Отчет

Vertex Pharma: David Altshuler, Chief Scientific Officer, Intends to Retire Aug 1, 2026 >VRTX

4 авг. 2025 г., 20:13 UTC

Отчет

Vertex Pharmaceuticals Backs FY25 Rev $11.85B-$12B >VRTX

4 авг. 2025 г., 20:09 UTC

Отчет

Viper Energy: Initiating Avg Daily Production Guidance for 3Q of 46,000 to 49,000 Bo/d (86,000 to 92,000 Boe/d) >VNOM

4 авг. 2025 г., 20:06 UTC

Отчет

Palantir Earnings Blow Past Wall Street's Stratospheric Expectations -- Barrons.com

4 авг. 2025 г., 20:01 UTC

Отчет

Vertex Pharmaceuticals 2Q Net $1.03B >VRTX

4 авг. 2025 г., 20:01 UTC

Отчет

Vertex Pharmaceuticals 2Q Adj EPS $4.52 >VRTX

4 авг. 2025 г., 20:01 UTC

Отчет

Vertex Pharmaceuticals 2Q Rev $2.96B >VRTX

4 авг. 2025 г., 20:01 UTC

Отчет

Vertex Pharmaceuticals 2Q EPS $3.99 >VRTX

4 авг. 2025 г., 19:41 UTC

Обсуждения рынка

U.S. Natural Gas Futures Settle Lower -- Market Talk

4 авг. 2025 г., 19:28 UTC

Обсуждения рынка

U.S. Hiring Expected to Recover Once Uncertainty Dissipates -- Market Talk

4 авг. 2025 г., 19:07 UTC

Обсуждения рынка

Oil Extends Losing Streak As OPEC+ to Raise Output -- Market Talk

4 авг. 2025 г., 18:27 UTC

Обсуждения рынка

Gold Climbs on Rate Cut Speculation -- Market Talk

Сравнение c конкурентами

Изменение цены

TruBridge Inc Прогноз

Целевая цена

By TipRanks

41.19% рост

Прогноз на 12 месяцев

Средняя 29 USD  41.19%

Максимум 29 USD

Минимум 29 USD

Основано на мнении 1 аналитиков Wall Street, спрогнозировавших целевые цены для TruBridge Inc на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Покупка

1 ratings

1

Покупка

0

Удержание

0

Продажа

Настроения

By Acuity

175 / 374Рейтинг в Здравоохранение

Новостные настроения

Neutral

Волатильность

Ниже среднего

Объем новостей (RCV)

Выше среднего

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании TruBridge Inc

TruBridge, Inc. provides healthcare solutions and services for community hospitals, clinics, and other healthcare systems in the United States and internationally. The company operates in three segments: Revenue Cycle Management (RCM), Electronic Health Record (HER), and Patient Engagement. It focuses on providing RCM solutions for care settings, regardless of primary healthcare information solutions provider along with business management, consulting, managed IT services, and analytics and business intelligence. The company provides acute care solutions and related services for community hospitals, and physician clinics; and patient engagement and empowerment technology solutions to improve patient outcomes and engagement strategies with care providers. In addition, it offers patient liability estimates eligibility verification, claim scrubbing and submission, remittance management, denial/audit management, and contract management; and offers RCM services, such as accounts receivable management, private pay service, medical coding, revenue cycle consulting, and other additional insurance and patient billing services. Further, it offers consulting and business management services; managed IT services; encoder solutions; patient management; financial accounting; clinical; patient care; and enterprise applications. Additionally, it offers TruBridge HER platform, including total system support, national client conference, continuing education, software releases, hardware replacement, cloud electronic health record, forms and supplies, and public cloud infrastructure services; post-acute care software systems, and support and maintenance services; and InstantPHR, an interactive portal and CHBase which funnels data from multiple sources into one platform. The company was formerly known as Computer Programs and Systems, Inc. and changed its name to TruBridge, Inc. in March 2024. TruBridge, Inc. was founded in 1979 and is headquartered in Mobile, Alabama.